Skip to main content
Erschienen in: International Orthopaedics 11/2011

01.11.2011 | Original Paper

Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency

verfasst von: Nikolaus A. Streich, David Zimmermann, Holger Schmitt, Gerrit Bode

Erschienen in: International Orthopaedics | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to determine the value of systemic biochemical markers of bone turnover—urine levels of cross-linked C-terminal telopeptide I (uCTX-I), urinary C-terminal telopeptide II (uCTX-II) and serum cartilage oligomeric matrix protein (sCOMP)—in the diagnosis of chondral defects after anterior cruciate ligament (ACL) rupture. Thirty-eight patients with previous ACL rupture were included.

Methods

Magnetic resonance imaging (MRI) of the injured and the intact knee joint was performed with volumetric measurement of volume and area of cartilage (VC/AC), area of subchondral bone (cAB), and area of subchondral bone denuded and eroded (dAB). Biochemical markers were measured using commercially available enzyme-linked immunoassays.

Results

MRI-based volumetric cartilage measurement showed significant differences between the injured and the intact knees. uCTX-I, sCOMP and in parts uCTX-II correlated well with MRI parameters. CTX-I showed a significant correlation with VC and AC of the whole knee joint.

Conclusions

The results suggest that uCTX-I, uCTX-II and sCOMP could identify patients with focal cartilage lesions from an early stage of osteoarthritis of the knee.
Literatur
1.
Zurück zum Zitat Petersson IF, Jacobsson LT (2002) Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 16:741–760PubMedCrossRef Petersson IF, Jacobsson LT (2002) Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 16:741–760PubMedCrossRef
2.
Zurück zum Zitat Kirwan JR, Elson CJ (2000) Is the progression of osteoarthritis phasic? Evidence and implications. J Rheumatol 27:834–836PubMed Kirwan JR, Elson CJ (2000) Is the progression of osteoarthritis phasic? Evidence and implications. J Rheumatol 27:834–836PubMed
3.
Zurück zum Zitat Vignon E, Garnero P, Delmas P, Avouac B, Bettica P, Boers M, Ehrich E, MacKillop N, Rovati L, Serni U et al (2001) Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis Cartilage 9:289–293PubMedCrossRef Vignon E, Garnero P, Delmas P, Avouac B, Bettica P, Boers M, Ehrich E, MacKillop N, Rovati L, Serni U et al (2001) Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers. Osteoarthritis Cartilage 9:289–293PubMedCrossRef
4.
Zurück zum Zitat Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953–968PubMedCrossRef Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953–968PubMedCrossRef
5.
Zurück zum Zitat Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant HK, Peterfy C, Burlet N, Ethgen D, Montague T et al (2006) Osteoarthritis, magnetic resonance imaging and biochemical markers: a one-year prospective study. Ann Rheum Dis 65:1050–1054PubMedCrossRef Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant HK, Peterfy C, Burlet N, Ethgen D, Montague T et al (2006) Osteoarthritis, magnetic resonance imaging and biochemical markers: a one-year prospective study. Ann Rheum Dis 65:1050–1054PubMedCrossRef
6.
Zurück zum Zitat Wang Y, Ebeling PR, Hanna F, O'Sullivan R, Cicuttini FM (2005) Relationship between bone markers and knee cartilage volume in healthy men. J Rheumatol 32:2200–2204PubMed Wang Y, Ebeling PR, Hanna F, O'Sullivan R, Cicuttini FM (2005) Relationship between bone markers and knee cartilage volume in healthy men. J Rheumatol 32:2200–2204PubMed
7.
Zurück zum Zitat Garnero P (2006) Use of biochemical markers to study and follow patients with osteoarthritis. Curr Rheumatol Rep 8:37–44PubMedCrossRef Garnero P (2006) Use of biochemical markers to study and follow patients with osteoarthritis. Curr Rheumatol Rep 8:37–44PubMedCrossRef
8.
Zurück zum Zitat Bettica P, Cline G, Hart DJ, Meyer J, Spector TD (2002) Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 46:3178–3184PubMedCrossRef Bettica P, Cline G, Hart DJ, Meyer J, Spector TD (2002) Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 46:3178–3184PubMedCrossRef
9.
Zurück zum Zitat Hudelmaier M, Glaser C, Englmeier KH, Reiser M, Putz R, Eckstein F (2003) Correlation of knee-joint cartilage morphology with muscle cross-sectional areas vs. anthropometric variables. Anat Rec A Discov Mol Cell Evol Biol 270:175–184PubMedCrossRef Hudelmaier M, Glaser C, Englmeier KH, Reiser M, Putz R, Eckstein F (2003) Correlation of knee-joint cartilage morphology with muscle cross-sectional areas vs. anthropometric variables. Anat Rec A Discov Mol Cell Evol Biol 270:175–184PubMedCrossRef
10.
Zurück zum Zitat Gandy SJ, Dieppe PA, Keen MC, Maciewicz RA, Watt I, Waterton JC (2002) No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. Osteoarthritis Cartilage 10:929–937PubMedCrossRef Gandy SJ, Dieppe PA, Keen MC, Maciewicz RA, Watt I, Waterton JC (2002) No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. Osteoarthritis Cartilage 10:929–937PubMedCrossRef
11.
Zurück zum Zitat Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60:619–626PubMedCrossRef Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60:619–626PubMedCrossRef
12.
Zurück zum Zitat Garnero P, Landewe R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 46:2847–2856PubMedCrossRef Garnero P, Landewe R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, Van Der Heijde D, Boonen A, Geusens P (2002) Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 46:2847–2856PubMedCrossRef
13.
Zurück zum Zitat Takahashi M, Suzuki M, Naitou K, Miyamoto S, Kushida K (1999) Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 38:133–138CrossRef Takahashi M, Suzuki M, Naitou K, Miyamoto S, Kushida K (1999) Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 38:133–138CrossRef
14.
Zurück zum Zitat Garnero P, Mazieres B, Gueguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M (2005) Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 32:697–703PubMed Garnero P, Mazieres B, Gueguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M (2005) Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 32:697–703PubMed
15.
Zurück zum Zitat Davis CR, Karl J, Granell R, Kirwan JR, Fasham J, Johansen J, Garnero P, Sharif M (2005) Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum 56:4038–4047CrossRef Davis CR, Karl J, Granell R, Kirwan JR, Fasham J, Johansen J, Garnero P, Sharif M (2005) Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum 56:4038–4047CrossRef
16.
Zurück zum Zitat Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P (2001) Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29:209–215PubMedCrossRef Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P (2001) Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29:209–215PubMedCrossRef
17.
Zurück zum Zitat Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C, Uitterlinden AG, Pols HA (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 50:2471–2478PubMedCrossRef Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C, Uitterlinden AG, Pols HA (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 50:2471–2478PubMedCrossRef
18.
Zurück zum Zitat Jordan KM, Syddall HE, Garnero P, Gineyts E, Dennison EM, Sayer AA, Delmas PD, Cooper C, Arden NK (2006) Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 65:871–877PubMedCrossRef Jordan KM, Syddall HE, Garnero P, Gineyts E, Dennison EM, Sayer AA, Delmas PD, Cooper C, Arden NK (2006) Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 65:871–877PubMedCrossRef
19.
Zurück zum Zitat Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis—association with disease progression. Rheumatology (Oxford) 46:938–943CrossRef Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis—association with disease progression. Rheumatology (Oxford) 46:938–943CrossRef
20.
Zurück zum Zitat Recklies AD, Baillargeon L, White C (1998) Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum 41:997–1006PubMedCrossRef Recklies AD, Baillargeon L, White C (1998) Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum 41:997–1006PubMedCrossRef
21.
Zurück zum Zitat Smith RK, Zunino L, Webbon PM, Heinegard D (1997) The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 16:255–271PubMedCrossRef Smith RK, Zunino L, Webbon PM, Heinegard D (1997) The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 16:255–271PubMedCrossRef
22.
Zurück zum Zitat Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ (1997) Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36:1151–1160PubMedCrossRef Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ (1997) Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36:1151–1160PubMedCrossRef
23.
Zurück zum Zitat Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W (2004) Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 71:70–76PubMedCrossRef Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W (2004) Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 71:70–76PubMedCrossRef
Metadaten
Titel
Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency
verfasst von
Nikolaus A. Streich
David Zimmermann
Holger Schmitt
Gerrit Bode
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
International Orthopaedics / Ausgabe 11/2011
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-010-1191-5

Weitere Artikel der Ausgabe 11/2011

International Orthopaedics 11/2011 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.